Citi raised the firm’s price target on Xylem to $126 from $122 and keeps a Neutral rating on the shares. The company reported strong Q4 results and its 2024 outlook indicates good earnings potential, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on XYL:
